Rare diseases
Investigational molecules
Locations
Back to Germany1 clinical trial in Plauen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical research focusing on HER2-negative breast cancer treatment strategies, specifically targeting hormone receptor-positive cases in first-line therapeutic settings.
Comprehensive evaluation of progression-free survival and overall survival rates, exploring temporal and spatial patterns in treatment response.
Investigation of Ribociclib therapy effectiveness through detailed analysis of response patterns and potential resistance development in advanced breast cancer cases.
Monitoring of treatment outcomes with focus on 12-month survival metrics and therapeutic effectiveness indicators.
Study of molecular patterns in breast cancer treatment, examining the comprehensive spatial and temporal aspects of therapeutic intervention.
Integration of molecular data to understand treatment efficacy and optimize therapeutic approaches for hormone receptor-positive breast cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
